Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Esteban Roberts is active.

Publication


Featured researches published by Esteban Roberts.


Journal of Thoracic Oncology | 2015

Comparison of Methods in the Detection of ALK and ROS1 Rearrangements in Lung Cancer

Toni-Maree Rogers; Prudence A. Russell; Gavin Wright; Zoe Wainer; Jia-Min Pang; Leigh A. Henricksen; Shalini Singh; Stacey Stanislaw; James Grille; Esteban Roberts; Benjamin Solomon; Stephen B. Fox

Introduction: The use of targeted therapies toward specific oncogenic driver mutations has become a critical factor in the treatment of patients with lung cancer. It is therefore essential to utilize tests with high performance characteristics. Fluorescence in situ hybridization (FISH) is the standard method for detecting anaplastic lymphoma kinase (ALK) and ROS1 rearrangements in non–small-cell lung cancer but the utility of other methods such as immunohistochemistry (IHC) and chromogenic in situ hybridization (CISH) is unclear. Methods: Three hundred and sixty-two lung cancer patients were tested with FISH, CISH, and IHC using three ALK antibodies (ALK1, 5A4, D5F3) and one ROS1 antibody in the detection of ALK and ROS1 rearrangements. Results: There was a 97.4% concordance (298 of 306) between FISH and CISH for detection of ALK rearrangements. The ROS1 rearrangement status had a 97% (291 of 300) concordance between CISH and FISH. ALK protein expression was observed in 6 of 341 samples with the ALK1 and 5A4 antibodies and 5 of 341 samples with D5F3. All three antibodies stained each of the ALK FISH-positive samples (100% sensitivity). ROS1 protein expression was observed in 2 of 322 samples. One of three samples with a ROS1 rearrangement by FISH showed ROS1 protein expression (33.3% sensitivity). Conclusion: Our findings show good correlation between FISH versus CISH in the detection of ALK and ROS1 rearrangements. FISH versus IHC showed good correlation in the detection of ALK rearrangements but showed weak correlation in the detection of ROS1 rearrangements. These results suggest CISH and IHC could be complimentary detection methods to FISH in the detection of ALK and ROS1 rearrangements.


PLOS ONE | 2013

Rapid Two-Temperature Formalin Fixation

David Chafin; Abbey Theiss; Esteban Roberts; Grace Borlee; Michael Otter; Geoffrey S. Baird

Formalin fixation is a mainstay of modern histopathologic analysis, yet the practice is poorly standardized and a significant potential source of preanalytical errors. Concerns of workflow and turnaround time drive interest in developing shorter fixation protocols, but rapid protocols can lead to poor histomorphology or inadequate downstream assay results. Additionally, assays such as immunohistochemistry for phosphorylated epitopes have historically been challenging in the context of formalin-fixed tissue, indicating that there may be room for improvement in this process that is fundamental to the practice of anatomic pathology. With these issues in mind, we studied basic formalin biochemistry to develop a novel formalin fixation protocol that involves a pre-incubation in subambient temperature formalin prior to a brief exposure to heated formalin. This new protocol is more rapid than standard protocols yet preserves histomorphology and yields tissue that is compatible with an expanded set of downstream clinical and research assays, including immunohistochemistry for phosphorylated epitopes.


Technology | 2016

Mapping cancer signaling networks by an integrated multiplexed tissue imaging platform

Esteban Roberts; Thomas Jacob; Karl Garsha; Damien Ramunno-Johnson; Franklin Ventura; James E. Korkola; Julia Ashworth-Sharpe; Donald E. Johnson; Christopher L. Corless; Megan L. Troxell; Michael Barnes; Joe W. Gray; Kandavel Shanmugam; Tania Q. Vu

Aberrant cellular signaling networks are implicated in major diseases including cancer, but are difficult to reliably quantitate, as many signaling proteins are expressed at low abundance and further reduced following specimen collection. MTIP is an integrated tissue-imaging platform that leverages bright, fluorescent reporters and sensitive spectral instrumentation, along with automated staining, image acquisition and non-parametric image analysis, to attain reproducible, multiplexed quantitation of signaling proteins in tissue. MTIP captured the phosphoactivity of six key PI3K/MAPK proteins (pAKTS473, pAKT308, pPRAS40, pS6, peIF4G and pERK1/2) at high precision (coefficient of variation, CV <10%), four-log dynamic range and subcellular resolution. We demonstrated the MTIP platforms capability to capture a diversity of PI3K/MAPK networks present in breast tumors. These protein networks are heterogeneously distributed across the tumor tissue and associated with subgroups of cells and underscore the impor...


Laboratory Investigation | 2017

Covalently deposited dyes: a new chromogen paradigm that facilitates analysis of multiple biomarkers in situ

William Day; Mark Lefever; Robert L. Ochs; Anne Pedata; Lauren Behman; Julia Ashworth-Sharpe; Donald Johnson; Eric May; James Grille; Esteban Roberts; Jerry W Kosmeder; Larry Morrison

Multiplexed analysis of multiple biomarkers in a tissue sample requires use of reporter dyes with specific spectral properties that enable discrimination of signals. Conventional chromogens with broad absorbance spectra, widely used in immunohistochemistry (IHC), offer limited utility for multiplexed detection. Many dyes with narrow absorbance spectra, eg rhodamines, fluoresceins, and cyanines, potentially useful for multiplexed detection are well-characterized; however, generation of a chromogenic reagent useful for IHC analysis has not been demonstrated. Studies reported herein demonstrate utility of tyramine-chemistry for synthesis of a wide variety of new chromogenic dye conjugates useful for multiplexed in situ analysis using conventional light microscopes. The dyes, useful individually or in blends to generate new colors, provide signal sensitivity and dynamic range similar to conventional DAB chromogen, while enabling analysis of co-localized biomarkers. It is anticipated that this new paradigm will enable generation of a wide variety of new chromogens, useful for both research and clinical biomarker analysis that will benefit clinicians and patients.


Proceedings of SPIE | 2015

Multi-modal contrast of tissue anatomy enables correlative biomarker imaging

Karl Garsha; Franklin Ventura; Gary Pestano; Michael Otter; Dea Nagy; Ray B. Nagle; Esteban Roberts; Michael Barnes

Optical imaging techniques are being developed that promise to increase the information content related to specific molecular reporters. Such modalities do not produce contrast in the structural context of the surrounding tissue, making it difficult to reconcile molecular information with morphological context. We report a solution that enables visualization of the tissue morphology on formalin-fixed, paraffin embedded sections prepared for analytical biomarker imaging. Our approach combines modes of transmitted darkfield and fluorescence contrast and computer visualization to produce 2-component image data analogous to the classical hematoxylin and eosin histological stain. An interferometric hyperspectral image capture mode enables measurement of multiplexed biomarkers in annotated anatomic regions. The system enables practical correlative analysis of molecular changes within areas of anatomic pathology.


Archive | 2012

METHOD FOR TISSUE SAMPLE FIXATION

Michael Otter; Abbey Pierson; David Chafin; Esteban Roberts


Archive | 2013

Method of identifying treatment responsive non-small cell lung cancer using anaplastic lymphoma kinase (alk) as a marker

Thomas M. Grogan; Hiro Nitta; Michael Barnes; Penny Towne; Shalini Singh; June Clements; Crystal Schemp; Esteban Roberts


Cancer Research | 2018

Abstract 1600: Expanded multiplexing capability in brightfield immunohistochemistry utilizing multiple chromogen chemistries and detection enzymes

Esteban Roberts; William Day; Brian D. Kelly; Nathan W. Polaske; Julia Ashworth-Sharpe; Donald E. Johnson; Mark Lefever; Jerry W Kosmeder; Hongjun Zhang; Jian Zhang; Tsu-Shuen Tsao; Michael Farrell; Joerg Bredno; Robert L. Ochs; Larry E. Morrison


American Journal of Clinical Pathology | 2015

Next-Generation Immunohistochemical Stains: True Multiplex (Triple) Immunohistochemical Panel for the Identification of Metastatic Carcinoma in Cytology Effusions

Charalambos Solomides; Marluce Bibbo; Rossitza Draganova-Tacheva; Ruth Birbe; Phoebe Holmes; James Casey; Lauren Behman; Esteban Roberts; Larry Morrison


Archive | 2013

Méthode d'identification d'un cancer du poumon autre qu'à petites cellules (nsclc) réagissant à un traitement au moyen de la kinase du lymphome anaplasique (alk) comme marqueur

Thomas M. Grogan; Hiro Nitta; Michael Barnes; Penny Towne; Shalini Singh; June Clements; Crystal Schemp; Esteban Roberts

Collaboration


Dive into the Esteban Roberts's collaboration.

Top Co-Authors

Avatar

Donald E. Johnson

Southwest Research Institute

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Robert L. Ochs

Baylor College of Medicine

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Gavin Wright

St. Vincent's Health System

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Grace Borlee

University of Washington

View shared research outputs
Top Co-Authors

Avatar

James Casey

Thomas Jefferson University Hospital

View shared research outputs
Researchain Logo
Decentralizing Knowledge